Staar Surgical Co. STAA

What this company does

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. As of January 2, 2026, the company had approximately 957 employees, of which 406 were employed outside the U.S. For the fiscal year ended January 2, 2026, the company generated 91% of its reported worldwide revenue from product sales outside the United States. STAAR products have been sold in more than 85 countries, with direct distribution in Japan, the U.S., Germany, Spain, Singapore, Canada, and the U.K. STAAR maintains operational and administrative facilities in the U.S., Switzerland, and Japan. Two customers, its China distributors who sell into China and Hong Kong, accounted for approximately 32% of its consolidated net sales during fiscal 2025. The company operates as one operating segment for financial reporting purposes, with 100% of its sales generated from the ophthalmic surgical product segment.

Written from the business description in STAAR SURGICAL CO's annual report to the U.S. Securities and Exchange Commission, filed 3 March 2026. Every sentence was checked against that document before publication.